• Fri news: New Novo obesity prospect linked to psychiatric side effects. Summit beats Keytruda in NSCLC. DermaSensor skin cancer detection device. Astellas digital health product. Sanofi MS data. See more on our front page

Biogen goes deep into biosimilars, slapping down $700M for a major stake in Samsung Bioepis

cafead

Administrator
Staff member
  • cafead   Jun 28, 2018 at 07:13: PM
via Biogen $BIIB was pretty careful when it allied with Samsung Bioepis back in 2011 — when George Scangos was CEO — taking a small minority stake in the company as it dipped its toe into biosimilar waters.

article source
 

<